Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Hepatitis C virus | Hepatitis C virus NS3 protease/helicase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0285 | 1 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0285 | 1 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0285 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0285 | 1 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0285 | 1 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0285 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0285 | 1 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0253 | 0.7709 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0285 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0176 | 0.2291 | 0.2291 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0285 | 1 | 0.5 |
Chlamydia trachomatis | sulfite reductase | 0.0176 | 0.2291 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0285 | 1 | 1 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0285 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0253 | 0.7709 | 0.5 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0285 | 1 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0285 | 1 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0285 | 1 | 1 |
Leishmania major | p450 reductase, putative | 0.0285 | 1 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0285 | 1 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0285 | 1 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0285 | 1 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0285 | 1 | 0.5 |
Trypanosoma cruzi | p450 reductase, putative | 0.0285 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0285 | 1 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0285 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | uM | Inhibitory concentration against Human pancreatic Serine protease chymotrypsin. | ChEMBL. | 12372533 |
IC50 (binding) | uM | Inhibitory concentration against Human leukocyte Elastase; NT denotes not tested | ChEMBL. | 12372533 |
IC50 (binding) | 0 uM | Inhibitory concentration against Human leukocyte Elastase; NT denotes not tested | ChEMBL. | 12372533 |
IC50 (binding) | NT 0 uM | Inhibitory concentration against Human pancreatic Serine protease chymotrypsin. | ChEMBL. | 12372533 |
Ki (binding) | = 0.009 uM | Binding affinity against Hepatitis C virus NS3 protease | ChEMBL. | 12372533 |
Ki (binding) | = 0.009 uM | Binding affinity against Hepatitis C virus NS3 protease | ChEMBL. | 12372533 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.